RxDoctor Payments Data

Joseph Beach, PA

Physician Assistant · Glendale, AZNPI 1265997225

Payments from drug & device makers

$2,217in general payments, 2019–2025

Across 66 payments — averaging $33.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$923
  • Stryker$286
  • AbbVie$226
  • Nalu Medical, Inc.$197
  • Tersera Therapeutics LLC$132
  • KCI USA, Inc.$116
  • plus $338 from 10 others

What the payments were for

  • Food & beverage$2,217100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,217 in reported general payments places this provider in the 80th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$60,221
Medicare patients
219
Services billed
5,669

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MovantikNaloxegol Oxalate31$13,581
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen319$11,656
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen284$8,730
Xtampza ErOxycodone Myristate26$8,620
Oxycodone Hcl228$3,867
Gabapentin230$3,635
Buprenorphine13$3,148
Pregabalin84$2,408
Morphine Sulfate ErMorphine Sulfate89$1,786
Lidocaine19$1,472
Tizanidine Hcl113$1,270
Baclofen51$1,245
Fentanyl11$1,031
Cyclobenzaprine Hcl85$948
Morphine Sulfate30$938

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$17$8,62026 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Glendale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →